Skip to main content
. 2019 Jan 1;16(2):253–263. doi: 10.7150/ijms.28361

Table 4.

Pharmacological therapy in ERA patients.

Pharmacological therapy Patients
Corticosteroids 22 (42,3%)
sDMARDs 41 (78,8%)
bDMARDs 18 (34,6%)